A review of lung transplantation for patients with α-1 antitrypsin deficiency

Amit Banga, Haala Rokadia, James K. Stoller

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

α-1 antitrypsin deficiency (AATD) is an autosomal codominant condition that predisposes one to emphysema because of the lack of proteolytic defense in the lung. Emphysema leading to respiratory failure is the most common cause of death in AATD, and AATD is currently the fourth most common indication for lung transplantation (LT) in the United States. Although the intraoperative management of LT for AATD resembles that of usual (AAT replete) chronic obstructive pulmonary disease, several special circumstances regard the selection, pretransplant and posttransplant management, and outcomes after LT in AATD. The current review begins with an overview of AATD, followed by a discussion regarding indications for LT and the impact of AATD on LT candidacy. We then review the available experience with outcomes after LT for AATD, while highlighting specific considerations for posttransplant care of these patients. ©

Original languageEnglish (US)
Pages (from-to)239-245
Number of pages7
JournalClinical Pulmonary Medicine
Volume22
Issue number5
DOIs
StatePublished - Sep 23 2015

Fingerprint

Lung Transplantation
Emphysema
Respiratory Insufficiency
Chronic Obstructive Pulmonary Disease
Cause of Death
Patient Care
Lung

Keywords

  • COPD
  • lung transplantation
  • α-1 antitrypsin deficiency

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

A review of lung transplantation for patients with α-1 antitrypsin deficiency. / Banga, Amit; Rokadia, Haala; Stoller, James K.

In: Clinical Pulmonary Medicine, Vol. 22, No. 5, 23.09.2015, p. 239-245.

Research output: Contribution to journalArticle

Banga, Amit ; Rokadia, Haala ; Stoller, James K. / A review of lung transplantation for patients with α-1 antitrypsin deficiency. In: Clinical Pulmonary Medicine. 2015 ; Vol. 22, No. 5. pp. 239-245.
@article{744c6bd5f87e4e42837e55216841c497,
title = "A review of lung transplantation for patients with α-1 antitrypsin deficiency",
abstract = "α-1 antitrypsin deficiency (AATD) is an autosomal codominant condition that predisposes one to emphysema because of the lack of proteolytic defense in the lung. Emphysema leading to respiratory failure is the most common cause of death in AATD, and AATD is currently the fourth most common indication for lung transplantation (LT) in the United States. Although the intraoperative management of LT for AATD resembles that of usual (AAT replete) chronic obstructive pulmonary disease, several special circumstances regard the selection, pretransplant and posttransplant management, and outcomes after LT in AATD. The current review begins with an overview of AATD, followed by a discussion regarding indications for LT and the impact of AATD on LT candidacy. We then review the available experience with outcomes after LT for AATD, while highlighting specific considerations for posttransplant care of these patients. {\circledC}",
keywords = "COPD, lung transplantation, α-1 antitrypsin deficiency",
author = "Amit Banga and Haala Rokadia and Stoller, {James K.}",
year = "2015",
month = "9",
day = "23",
doi = "10.1097/CPM.0000000000000119",
language = "English (US)",
volume = "22",
pages = "239--245",
journal = "Clinical Pulmonary Medicine",
issn = "1068-0640",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - A review of lung transplantation for patients with α-1 antitrypsin deficiency

AU - Banga, Amit

AU - Rokadia, Haala

AU - Stoller, James K.

PY - 2015/9/23

Y1 - 2015/9/23

N2 - α-1 antitrypsin deficiency (AATD) is an autosomal codominant condition that predisposes one to emphysema because of the lack of proteolytic defense in the lung. Emphysema leading to respiratory failure is the most common cause of death in AATD, and AATD is currently the fourth most common indication for lung transplantation (LT) in the United States. Although the intraoperative management of LT for AATD resembles that of usual (AAT replete) chronic obstructive pulmonary disease, several special circumstances regard the selection, pretransplant and posttransplant management, and outcomes after LT in AATD. The current review begins with an overview of AATD, followed by a discussion regarding indications for LT and the impact of AATD on LT candidacy. We then review the available experience with outcomes after LT for AATD, while highlighting specific considerations for posttransplant care of these patients. ©

AB - α-1 antitrypsin deficiency (AATD) is an autosomal codominant condition that predisposes one to emphysema because of the lack of proteolytic defense in the lung. Emphysema leading to respiratory failure is the most common cause of death in AATD, and AATD is currently the fourth most common indication for lung transplantation (LT) in the United States. Although the intraoperative management of LT for AATD resembles that of usual (AAT replete) chronic obstructive pulmonary disease, several special circumstances regard the selection, pretransplant and posttransplant management, and outcomes after LT in AATD. The current review begins with an overview of AATD, followed by a discussion regarding indications for LT and the impact of AATD on LT candidacy. We then review the available experience with outcomes after LT for AATD, while highlighting specific considerations for posttransplant care of these patients. ©

KW - COPD

KW - lung transplantation

KW - α-1 antitrypsin deficiency

UR - http://www.scopus.com/inward/record.url?scp=84942088532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942088532&partnerID=8YFLogxK

U2 - 10.1097/CPM.0000000000000119

DO - 10.1097/CPM.0000000000000119

M3 - Article

AN - SCOPUS:84942088532

VL - 22

SP - 239

EP - 245

JO - Clinical Pulmonary Medicine

JF - Clinical Pulmonary Medicine

SN - 1068-0640

IS - 5

ER -